Girx, LLC

Specifica Inc is a Santa Fe-based company specializing in the creation of exceptional Antibody Libraries. Their visionary antibody technologies and deal structures empower clients to generate antibody drugs against any target, with antibodies selected from their libraries exhibiting high affinities and developability properties comparable to or better than clinical antibodies on the market. With a focus on diversity and developability, Specifica's Generation 3 Platform offers exclusive assets, full platform transfer, and the ability to collaborate and customize library designs. Their integrated antibody discovery platform, including next generation sequencing and machine learning, enables the generation of diverse, high affinity, drug-like, and developable antibodies. Their straightforward terms and tailored structures ensure a seamless partnership experience.Generated from the website

The Heffter Research Institute, based in Santa Fe, NM, is a non-profit scientific organization dedicated to advancing research on psilocybin and other psychedelics for the treatment of addictions and mental disorders. With a focus on conducting high-quality scientific studies, the institute aims to contribute to a greater understanding of the mind, improve the human condition, and alleviate suffering. Since its establishment in 1993, the Heffter Research Institute has played a crucial role in designing, reviewing, and funding leading studies on psilocybin at renowned research institutions in the US and Europe. Their research has explored the potential of psilocybin in treating cancer-related distress, addiction, and understanding the relationship between the psychedelic experience and spirituality. As an independently funded organization, the institute relies on continuous funding to support their critical research, believing that psychedelics hold untapped potential that can be harnessed through scientific investigation.Generated from the website

Natures Toolbox Inc. (NTx), located in Rio Rancho, New Mexico, is revolutionizing biomanufacturing by democratizing the production of RNA and proteins. Their innovative technologies, including the NTxscribe and NTxpress systems, enable the efficient and scalable manufacturing of complex RNA, such as mRNA and saRNA, at a lower cost than traditional methods. NTx is committed to advancing healthcare through next-generation biomanufacturing solutions that are eco-friendly and sustainable. By empowering biopharmaceutical companies to innovate faster and streamline production, NTx aims to enhance global health and accessibility to vital therapeutics and vaccines. Generated from the website